SNOA

Sonoma Pharmaceuticals Stock Price

6.42
-0.04 (-0.62%)
Upgrade to Real-Time
Regular Market
6.42
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Sonoma Pharmaceuticals Inc SNOA NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.04 -0.62% 6.42 6.40 6.492 6.40 6.46 15:15:02
Bid Price Ask Price Spread Spread % News
6.40 6.44 0.04 0.62% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
167 28,279 $ 6.42 $ 181,629 1,354,501 3.33 - 19.54
Last Trade Time Type Quantity Stock Price Currency
15:15:01 53 $ 6.42 USD

Sonoma Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 11.41M 1.78M - $ 18.97M $ -4.44M -13.27 -2.57
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Sonoma Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SNOA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week7.447.806.406.8548,690-1.02-13.71%
1 Month8.649.006.127.04127,248-2.22-25.69%
3 Months5.2819.544.609.42649,9091.1421.59%
6 Months4.3919.543.559.24318,5962.0346.24%
1 Year7.5019.543.339.09167,867-1.08-14.4%
3 Years6.7919.540.63995.53118,750-0.37-5.45%
5 Years1.629919.540.63993.76136,5544.79293.89%

Sonoma Pharmaceuticals Description

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The majority of the company revenue comes from the United States.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.